Description
Description: JANUVIA is a medication containing the active substance Sitagliptin, available in tablet form with a strength of 100 mg per tablet. Manufactured by MSD, JANUVIA is used in the management of type 2 diabetes mellitus (T2DM) to help control blood sugar levels. Each pack of JANUVIA contains 28 tablets and is intended for oral administration.
Medical Uses: JANUVIA (Sitagliptin) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It belongs to a class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by increasing the levels of incretin hormones in the body. Incretins help regulate blood sugar levels by stimulating insulin release and decreasing the production of glucagon, a hormone that raises blood sugar levels. By inhibiting the enzyme DPP-4, JANUVIA prolongs the action of incretins, leading to improved glucose control.
Administration: JANUVIA tablets are taken orally, typically once daily, with or without food, as directed by a healthcare professional. The dosage may vary depending on factors such as the patient’s medical condition, kidney function, and response to treatment. JANUVIA can be used alone or in combination with other antidiabetic medications, such as metformin or sulfonylureas, to achieve optimal glycemic control.
Manufacturer: JANUVIA tablets are manufactured by MSD, a global healthcare company committed to developing innovative therapies for various medical conditions. MSD adheres to stringent manufacturing standards to ensure the safety, efficacy, and reliability of their products.
Storage: JANUVIA tablets should be stored at room temperature (between 20°C and 25°C) in a dry place away from direct sunlight and moisture. It is essential to keep the medication out of reach of children and pets. Patients should not use JANUVIA tablets beyond their expiration date.
Precautions:
- JANUVIA should only be used under the supervision of a qualified healthcare professional experienced in the management of diabetes.
- Patients should undergo regular monitoring of blood glucose levels and kidney function during treatment with JANUVIA.
- Sitagliptin may interact with other medications, so patients should inform their healthcare provider about all current medications, including prescription drugs, over-the-counter medications, and supplements.
Side Effects: Common side effects of JANUVIA may include:
- Upper respiratory tract infection
- Headache
- Nasopharyngitis
- Hypoglycemia (low blood sugar) when used in combination with other antidiabetic medications
Serious side effects such as pancreatitis, allergic reactions, and severe joint pain are rare but possible. Patients should seek medical attention if they experience any severe or persistent side effects while taking JANUVIA.
Disclaimer: JANUVIA tablets should only be used under the supervision of a qualified healthcare professional and as part of a comprehensive treatment plan for type 2 diabetes mellitus. This description provides general information about the medication and its uses and should not replace medical advice from a healthcare provider.
Reviews
There are no reviews yet.